Cancer Screening Market in India (2018-2023)
- Netscribes (India) Pvt. Ltd.
- September 2018
- 75 pages
The Asia-Pacific is a growing region and holds lots of positive socio-economic factors suitable for the growth and progress of the market primarily because of its association with the global value chains (GVCs). India being a part of the Asia-Pacific region, holds key access to the regions close association with trade agreements with global growth centers. The total market for diagnostic and medical equipment in India is worth USD 14.73 billion and is forecasted to expand at an annual rate of 13% CAGR during the forecast period 2018-2023.
Key growth factors
With the growing population, the cancer burden continues to grow in India. Hence, arises the need of more precision based medical technologies and methodologies to cater to the need of the region.
Threats and key players
Though the Indian market is burgeoning with opportunities .It needs to focus more on its tax regime and easier business conditions. More than 1 million cases of cancer are diagnosed in India every year and this number is bound to increase by 5 billion. Taking into considerations the risks, the region is bound to encounter human and economic costs from the increasing rate of cancer.
The key players operating in the cancer screening market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Siemens Healthineers, Philips and GE Healthcare.
What is covered in the report?
1. Overview of the cancer screening market in India.
2. Market drivers and challenges in the cancer screening market in India.
3. Market trends in the cancer screening market in India.
4. Historical, current and forecasted market size data for segments based on end users (hospitals, laboratories, and independent physicians and clinics).
5. Historical, current and forecasted market size data for segments based on screening type (Laboratory, genetic, biopsy, imaging and endoscopy testing).
6. Historical, current and forecasted market size data for segmentation based on application type (lung, breast, melanoma, kidney and colorectal cancer).
7. Analysis of the competitive landscape and profiles of the major companies operating in the market.
o Understand the demand for cancer screening market in India to determine the viability of the market.
o Identify the developed and emerging markets where cancer screening market in India is sold.
o Identify the challenge areas and address them.
o Develop strategies based on the drivers, trends and highlights for each of the segments.
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
o Recognize the key competitors of this market and respond accordingly.
o Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth.
o Define the competitive positioning by comparing the products and services with the key players in the market.
With the given market data, Netscribes offers customizations according to specific needs. Write to us at firstname.lastname@example.org.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017